Zhihong Wang
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 5
- Molecular Biology top 10%
- Melanoma and MAPK Pathways 10
- Protein Kinase Regulation and GTPase Signaling 10
- Histone Deacetylase Inhibitors Research 6
- Peroxisome Proliferator-Activated Receptors 6
- RNA modifications and cancer 5
- Hematology top 10%
- Oncology top 10%
- HER2/EGFR in Cancer Research 6
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- Philip A. ColeTiannan WeiJin ShangZhi‐Zhong ChenWenbing WuDaniel J. LeahyEric L. HeggYana Li
- Journals
- Journal of Biological Chemistry (3 papers)Journal of Clinical Oncology (1 paper)Blood (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Zhihong Wang
77 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 334
- Molecular Biology 1.2k
- Hematology 103
- Oncology 237
- Immunology 98
Countries citing papers authored by Zhihong Wang
This map shows the geographic impact of Zhihong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihong Wang more than expected).
Fields of papers citing papers by Zhihong Wang
This network shows the impact of papers produced by Zhihong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihong Wang. The network helps show where Zhihong Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhihong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 2 | |
| 11 | 2019 | 91 | |
| 12 | 2018 | 29 | |
| 13 | 2017 | 1 | |
| 14 | 2016 | 6 | |
| 15 | 2013 | 20 | |
| 16 | 2012 | 6 | |
| 17 | 2011 | 78 | |
| 18 | 2009 | 1 | |
| 19 | 2008 | 16 | |
| 20 | 2008 | 1 |
About Zhihong Wang
Zhihong Wang is a scholar working on Molecular Biology, Cancer Research and Oncology, having authored 81 papers that have together received 1.6k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (10 papers), Protein Kinase Regulation and GTPase Signaling (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Histone Deacetylase Inhibitors Research (6 papers), Peroxisome Proliferator-Activated Receptors (6 papers), HER2/EGFR in Cancer Research (6 papers), RNA modifications and cancer (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (334 citations), Molecular Biology (1.2k citations) and Hematology (103 citations). Zhihong Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Philip A. Cole, Tiannan Wei, Jin Shang, Zhi‐Zhong Chen, Wenbing Wu, Daniel J. Leahy, Eric L. Hegg, Yana Li, Jeffrey W. Taub and Holly Edwards. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.